Skip to main content
. 2021 Jul 19;8:697272. doi: 10.3389/fcvm.2021.697272

Table 5.

Serum levels of TMAO before and after 4-week and 8-week treatment with Taurisolo® in study participants stratified for age.

Baseline t-4wk t-8wk
Mean ±SD Mean ±SD Δ% (vs. t0) p (vs. t0) Mean ±SD Δ% (vs. t0) p (vs. t0)
18–40 years (n = 14) 1.89 ± 0.32 0.78 ± 0.56 −58.92 <0.0001 0.75 ± 0.33 −60.08 <0.0001
41–60 years (n = 31) 2.53 ± 3.16 1.29 ± 1.32 −49.13 <0.001 0.65 ± 0.80 −74.24 <0.001
>61 years (n = 63) 2.55 ± 1.95 1.41 ± 1.29 −44.73 <0.0001 0.46 ± 0.34 −81.87 <0.0001

Statistical significance was calculated with Student's t-test; p < 0.05 was considered as significant.